Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Cervical Cancer Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global cervical cancer diagnostics market grew at a CAGR of around 7% during 2015-2020. Looking forward, IMARC Group expects the market to continue its moderate growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor. 

Cervical cancer diagnostics rely on a series of advanced laboratory tests, tools and procedures to evaluate abnormal cells or strains of the human papillomavirus (HPV). They are performed by taking a sample of the tissue obtained through conization, punch biopsy, endocervical curettage and the electrical wire loop for a thorough examination of the cervix during colposcopy. After detection, tests like blood, chest X-ray, body computed tomography (CT) scan, magnetic resonance imaging (MRI), positron emission tomography (PET) scan and visual examination of bladder and rectum are conducted to determine the disease stage.

A considerable rise in the number of individuals diagnosed with sexually transmitted infections (STIs), such as syphilis, chlamydia, gonorrhea and acquired immune deficiency syndrome (HIV/AIDS), is escalating the risk of HPV infection worldwide. This, along with the growing number of smokers, which increases the chances of developing cervical cancer, represents one of the key factors bolstering the market growth. Furthermore, the rising awareness about early diagnosis is encouraging the adoption of HPV home testing kits that provide quick and accurate test results. The presence of favorable reimbursement policies also supports the market growth. Apart from this, rising preferences for personalized treatment plans are escalating the demand for cervical cancer diagnostics. Additionally, the availability of a range of other treatment options, including surgery, radiation therapy, chemotherapy, cone biopsy, immunotherapy and trachelectomy, is contributing to the market growth. Moreover, the growing emphasis on developing low-cost and efficient testing products is anticipated to fuel the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cervical cancer diagnostics market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on test type and age group.

Breakup by Test Type:

  • Pap Testing
  • HPV Testing
  • Cervical Biopsies
  • Colposcopy
  • Others
     

Breakup by Age Group:

  • 20 to 35 years
  • Above 35 years
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arbor Vita Corporation, Becton, Dickinson and Company, Cooper Surgical Inc., F. Hoffmann-La Roche AG, Guided Therapeutics Inc., Hologic Inc., Qiagen, Quest Diagnostics Incorporated and Siemens Healthcare GmbH.

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Test Type, Age Group, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Arbor Vita Corporation, Becton, Dickinson and Company, Cooper Surgical Inc., F. Hoffmann-La Roche AG, Guided Therapeutics Inc., Hologic Inc., Qiagen, Quest Diagnostics Incorporated and Siemens Healthcare GmbH
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Questions Answered in This Report:

  • How has the global cervical cancer diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global cervical cancer diagnostics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the age group?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global cervical cancer diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

1   Preface
2   Scope and Methodology

    2.1   Objectives of the Study
    2.2   Stakeholders
    2.3   Data Sources
        2.3.1   Primary Sources
        2.3.2   Secondary Sources
    2.4   Market Estimation
        2.4.1   Bottom-Up Approach
        2.4.2   Top-Down Approach
    2.5   Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1   Overview
    4.2   Key Industry Trends
5   Global Cervical Cancer Diagnostics Market
    5.1   Market Overview
    5.2   Market Performance
    5.3   Impact of COVID-19
    5.4   Market Forecast
6   Market Breakup by Test Type
    6.1   Pap Testing
        6.1.1  Market Trends
        6.1.2  Market Forecast
    6.2   HPV Testing
        6.2.1  Market Trends
        6.2.2  Market Forecast
    6.3   Cervical Biopsies
        6.3.1  Market Trends
        6.3.2  Market Forecast
    6.4   Colposcopy
        6.4.1  Market Trends
        6.4.2  Market Forecast
    6.5   Others
        6.5.1  Market Trends
        6.5.2  Market Forecast
7   Market Breakup by Age Group
     7.1   20 to 35 years
        7.1.1  Market Trends
        7.1.2  Market Forecast
     7.2   Above 35 years
        7.2.1  Market Trends
        7.2.2  Market Forecast
8   Market Breakup by Region
    8.1   North America
          8.1.1   United States
               8.1.1.1  Market Trends
               8.1.1.2  Market Forecast
          8.1.2   Canada
               8.1.2.1  Market Trends
               8.1.2.2  Market Forecast
    8.2   Asia-Pacific
          8.2.1   China
               8.2.1.1  Market Trends
               8.2.1.2  Market Forecast
          8.2.2   Japan
               8.2.2.1  Market Trends
               8.2.2.2  Market Forecast
          8.2.3   India
               8.2.3.1  Market Trends
               8.2.3.2  Market Forecast
          8.2.4   South Korea
               8.2.4.1  Market Trends
               8.2.4.2  Market Forecast
          8.2.5   Australia
               8.2.5.1  Market Trends
               8.2.5.2  Market Forecast
          8.2.6   Indonesia
               8.2.6.1  Market Trends
               8.2.6.2  Market Forecast
          8.2.7   Others
               8.2.7.1  Market Trends
               8.2.7.2  Market Forecast
    8.3   Europe
          8.3.1   Germany
               8.3.1.1  Market Trends
               8.3.1.2  Market Forecast
          8.3.2   France
               8.3.2.1  Market Trends
               8.3.2.2  Market Forecast
          8.3.3   United Kingdom
               8.3.3.1  Market Trends
               8.3.3.2  Market Forecast
          8.3.4   Italy
               8.3.4.1  Market Trends
               8.3.4.2  Market Forecast
          8.3.5   Spain
               8.3.5.1  Market Trends
               8.3.5.2  Market Forecast
          8.3.6   Russia
               8.3.6.1  Market Trends
               8.3.6.2  Market Forecast
          8.3.7   Others
               8.3.7.1  Market Trends
               8.3.7.2  Market Forecast
    8.4   Latin America
          8.4.1   Brazil
               8.4.1.1  Market Trends
               8.4.1.2  Market Forecast
          8.4.2   Mexico
               8.4.2.1  Market Trends
               8.4.2.2  Market Forecast
          8.4.3   Others
               8.4.3.1  Market Trends
               8.4.3.2  Market Forecast
    8.5   Middle East and Africa
          8.5.1  Market Trends
          8.5.2  Market Breakup by Country
          8.5.3  Market Forecast
9    SWOT Analysis
    9.1   Overview
    9.2   Strengths
    9.3   Weaknesses
    9.4   Opportunities
    9.5   Threats
10    Value Chain Analysis
11    Porters Five Forces Analysis
    11.1   Overview
    11.2   Bargaining Power of Buyers
    11.3   Bargaining Power of Suppliers
    11.4   Degree of Competition
    11.5   Threat of New Entrants
    11.6   Threat of Substitutes
12    Price Analysis
13    Competitive Landscape
    13.1   Market Structure
    13.2   Key Players
    13.3   Profiles of Key Players
         13.3.1   Abbott Laboratories
              13.3.1.1   Company Overview
              13.3.1.2   Product Portfolio
              13.3.1.3   Financials
              13.3.1.4   SWOT Analysis
         13.3.2   Arbor Vita Corporation
              13.3.2.1   Company Overview
              13.3.2.2   Product Portfolio
         13.3.3   Becton, Dickinson and Company
              13.3.3.1   Company Overview
              13.3.3.2   Product Portfolio
              13.3.3.3   Financials
              13.3.3.4   SWOT Analysis
         13.3.4   Cooper Surgical Inc.
              13.3.4.1   Company Overview
              13.3.4.2   Product Portfolio
         13.3.5   F. Hoffmann-La Roche AG
              13.3.5.1   Company Overview
              13.3.5.2   Product Portfolio
              13.3.5.3   Financials
         13.3.6   Guided Therapeutics Inc.
              13.3.6.1   Company Overview
              13.3.6.2   Product Portfolio
              13.3.6.3   SWOT Analysis
         13.3.7   Hologic Inc.
              13.3.7.1   Company Overview
              13.3.7.2   Product Portfolio
              13.3.7.3   Financials
              13.3.7.4   SWOT Analysis
         13.3.8   Qiagen
              13.3.8.1   Company Overview
              13.3.8.2   Product Portfolio
              13.3.8.3   Financials
              13.3.8.4   SWOT Analysis
         13.3.9   Quest Diagnostics Incorporated
              13.3.9.1   Company Overview
              13.3.9.2   Product Portfolio
              13.3.9.3   Financials
              13.3.9.4   SWOT Analysis
         13.3.10   Siemens Healthcare GmbH
              13.3.10.1   Company Overview
              13.3.10.2   Product Portfolio
              13.3.10.3   SWOT Analysis

List of Figures

Figure 1: Global: Cervical Cancer Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Cervical Cancer Diagnostics Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Cervical Cancer Diagnostics Market: Breakup by Test Type (in %), 2020
Figure 5: Global: Cervical Cancer Diagnostics Market: Breakup by Age Group (in %), 2020
Figure 6: Global: Cervical Cancer Diagnostics Market: Breakup by Region (in %), 2020
Figure 7: Global: Cervical Cancer Diagnostics (Pap Testing) Market: Sales Value (in Million US$), 2015 & 2020
Figure 8: Global: Cervical Cancer Diagnostics (Pap Testing) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 9: Global: Cervical Cancer Diagnostics (HPV Testing) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Cervical Cancer Diagnostics (HPV Testing) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Cervical Cancer Diagnostics (Cervical Biopsies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Cervical Cancer Diagnostics (Cervical Biopsies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Cervical Cancer Diagnostics (Colposcopy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Cervical Cancer Diagnostics (Colposcopy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Cervical Cancer Diagnostics (Others) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Cervical Cancer Diagnostics (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Cervical Cancer Diagnostics (20 to 35 years) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Cervical Cancer Diagnostics (20 to 35 years) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Cervical Cancer Diagnostics (Above 35 years) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Cervical Cancer Diagnostics (Above 35 years) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: North America: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: North America: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: North America: Cervical Cancer Diagnostics Market: Breakup by Country (in %), 2020
Figure 24: United States: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: United States: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Canada: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Canada: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Asia-Pacific: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Asia-Pacific: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Asia-Pacific: Cervical Cancer Diagnostics Market: Breakup by Country (in %), 2020
Figure 31: China: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: China: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Japan: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Japan: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: India: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: India: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: South Korea: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: South Korea: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Australia: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Australia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Indonesia: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Indonesia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Europe: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Europe: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: Europe: Cervical Cancer Diagnostics Market: Breakup by Country (in %), 2020
Figure 48: Germany: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Germany: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: France: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: France: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: United Kingdom: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: United Kingdom: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Italy: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: Italy: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Spain: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Spain: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Russia: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Russia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Latin America: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Latin America: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Latin America: Cervical Cancer Diagnostics Market: Breakup by Country (in %), 2020
Figure 65: Brazil: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: Brazil: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: Mexico: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: Mexico: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Middle East and Africa: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Middle East and Africa: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Middle East and Africa: Cervical Cancer Diagnostics Market: Breakup by Country (in %), 2020
Figure 74: Global: Cervical Cancer Diagnostics Industry: SWOT Analysis
Figure 75: Global: Cervical Cancer Diagnostics Industry: Value Chain Analysis
Figure 76: Global: Cervical Cancer Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Cervical Cancer Diagnostics Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2021-2026
Table 3: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Age Group (in Million US$), 2021-2026
Table 4: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 5: Global: Cervical Cancer Diagnostics Market: Competitive Structure
Table 6: Global: Cervical Cancer Diagnostics Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links